Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
RTX vs CRMD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
RTX Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 5–4 Matrix Metrics)
RTX Overall Winner
6-Pillar Tally: RTX 4 – 2 CRMD
Matrix Metrics: RTX 5 – 4 CRMD
As of Nov 16, 2026, RTX Corporation (RTX) is the stronger overall head-to-head candidate over CorMedix Inc. (CRMD) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). RTX carries a Unified Composite Score of 53.4/100 (HOLD) at $194.95 (24.5x Forward P/E, 13.1% operating margin), whereas CRMD carries 53.2/100 (HOLD) at $4.92 (49.0x Forward P/E, 41.0% operating margin).
- Technical & Structure Timing Caution: RTX trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 51.5); meanwhile CRMD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About RTX vs CRMD
RTX
Head-to-Head Winner
RTX Corporation
$194.95
-1.83% 1D
Market Cap
$267.7B
TTM Revenue
$96.0B
Forward P/E
24.5x
Beta / 30D Vol
0.28β · 29% Vol
Unified Composite Score
53.4
HOLD
Tech 44.0
Fund 45.0
Flow 55.0
Mom 31.1
Weinstein Technical Phase
Neutral · Hold
CRMD
CorMedix Inc.
$4.92
+5.47% 1D
Market Cap
$384.7M
TTM Revenue
$1.05B
Forward P/E
49.0x
Beta / 30D Vol
1.20β · 107% Vol
Unified Composite Score
53.2
HOLD
Tech 60.0
Fund 60.0
Flow 69.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (RTX 4 – 2 CRMD)
1. Valuation Multiples
RTX
Forward P/E
24.5x
49.0x
Trailing P/E
32.2x
2.4x
PEG Ratio
2.15x
3.79x
EV / Revenue
3.1x
N/M
2. Growth & Scale
RTX
Revenue Growth (YoY)
+11.1%
-47.7%
Earnings Growth (YoY)
+34.0%
+6.7%
TTM Revenue (USD)
$96.0B
$1.05B
Market Cap
$267.7B
$384.7M
3. Profitability & Quality
CRMD
Gross Margin
21.1%
87.4%
Operating Margin
13.1%
41.0%
Net Profit Margin
8.8%
15.5%
Return on Equity (ROE)
12.8%
15.3%
4. Balance Sheet & Cash Flow
CRMD
Cash Generation (TTM)
$9.13B
$785M
Cash Flow Margin
9.5%
74.6%
Net Cash / Leverage
$29.7B Net Debt (0.56x D/E)
$535M Net Cash
Dividend Yield
1.40%
None (0.00%)
5. Options & Positioning
RTX
Options Structure Phase
CONSOLIDATION
BREAKDOWN
Current IV / %ile
49.8% (67th %ile)
56.3% (25th %ile)
Put/Call OI Skew
0.73x (Call-Skewed)
0.69x (Call-Skewed)
OBV Trend / Tech Phase
NEUTRAL · Neutral
DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat
RTX
OpEx & R&D Intensity
8.0% of Rev ($7.68B)
46.4% of Rev ($488M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Concentrated Oligopoly Moat
High-Margin Pricing Power Moat
Supply-Chain Role
Aerospace & Defense Operator
Biotechnology Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: RTX (5) vs CRMD (4)| Institutional Metric | RTX | CRMD | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $267.7B | $384.7M | RTX | |
| Trailing P/E Ratio | 32.2x | 2.4x | CRMD | |
| Forward P/E Ratio | 24.5x | 49.0x | RTX | |
| Revenue Growth (YoY) | +11.1% | -47.7% | RTX | |
| Operating Margin (TTM) | 13.1% | 41.0% | CRMD | |
| Net Profit Margin | 8.8% | 15.5% | CRMD | |
| Return on Equity (ROE) | 12.8% | 15.3% | CRMD | |
| 52-Week Range Position | 47% ($167–$227) | 3% ($5–$13) | RTX | |
| Beta / 30D Volatility | 0.28β · 29% Vol | 1.20β · 107% Vol | RTX | |
| Unified Institutional Score | 53.4 / 100 (HOLD) | 53.2 / 100 (HOLD) | Tie | |
| Trailing 12M Revenue (USD) | $96.0B | $1.05B | Scale | |
| Gross Profit Margin (TTM) | 21.1% | 87.4% | Quality | |
| PEG Ratio & EV / Revenue | 2.15x PEG · 3.1x EV/Rev | 3.79x PEG · N/M EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $9.13B ($29.7B Net Debt (0.56x D/E)) | $785M ($535M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
RTX +32.83 pp
3M Horizon
RTX +26.3 pp
6M Horizon
RTX +48.66 pp
1Y Horizon
RTX +68.23 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | RTX Revenue | CRMD Revenue | RTX Op. Margin | CRMD Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $34.7B | $0M | 8.3% | -6250.4% | RTX |
| FY2019 | $45.4B | $0M | 10.8% | -7416.3% | RTX |
| FY2020 | $56.6B | $0M | -3.3% | -11378.4% | RTX |
| FY2021 | $64.4B | $0M | 8.0% | -15417.5% | RTX |
| FY2022 | $67.1B | $0M | 8.2% | -46819.9% | RTX |
| FY2023 | $68.9B | N/A | 5.2% | N/A | RTX |
| FY2024 | $80.7B | $40M | 8.1% | -51.4% | RTX |
| FY2025 | $88.6B | $310M | 10.5% | 48.2% | CRMD |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
RTX
CONSOLIDATION
Current IV
49.8%
IV Percentile
67th %ile
Put/Call OI Skew
0.73x (Call-Skewed)
IV Regime
Elevated (60th–80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact RTX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
CRMD
BREAKDOWN
Current IV
56.3%
IV Percentile
25th %ile
Put/Call OI Skew
0.69x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact CRMD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
RTX Moat Profile
Concentrated Oligopoly Moat
Aerospace & Defense Operator
OpEx & R&D Reinvestment
8.0% of Rev ($7.68B)
90D Engineering Disclosures
0 Published · Drone Autonomy / Counter-UAS
CRMD Moat Profile
High-Margin Pricing Power Moat
Biotechnology Operator
OpEx & R&D Reinvestment
46.4% of Rev ($488M)
90D Engineering Disclosures
0 Published
Investor FAQ RTX vs CRMD Key Questions & Quantitative Answers
As of Nov 16, 2026, RTX Corporation (RTX) is the stronger overall head-to-head candidate over CorMedix Inc. (CRMD) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). RTX carries a Unified Composite Score of 53.4/100 (HOLD) at $194.95 (24.5x Forward P/E, 13.1% operating margin), whereas CRMD carries 53.2/100 (HOLD) at $4.92 (49.0x Forward P/E, 41.0% operating margin). Technical & Structure Timing Caution: RTX trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 51.5); meanwhile CRMD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
RTX leads the Growth & Scale pillar: RTX posts +11.1% YoY revenue growth and +34.0% YoY earnings growth on $96.0B TTM revenue (21.1% gross margin, 13.1% operating margin), compared with CRMD at -47.7% YoY revenue growth and +6.7% YoY earnings growth on $1.05B TTM revenue (87.4% gross margin, 41.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), RTX cumulative revenue shifted +155.3% while CRMD shifted +675.0%. In operating R&D and SG&A reinvestment, RTX deploys 8.0% of Rev ($7.68B) (0 90-day corporate R&D disclosures) versus 46.4% of Rev ($488M) (0 disclosures) for CRMD.
RTX screens cheaper on headline valuation multiples. RTX trades at 24.5x Forward P/E, 32.2x Trailing P/E, 2.15x PEG, and 3.1x EV/Revenue (9.5% FCF margin), whereas CRMD trades at 49.0x Forward P/E, 2.4x Trailing P/E, 3.79x PEG, and N/M EV/Revenue (74.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RTX (12.8% ROE) versus CRMD (15.3% ROE) capital efficiency.
In options market volatility and institutional positioning, RTX carries 49.8% implied volatility (67th %ile, Elevated (60th–80th %ile)), a 0.73x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.28β · 29% Vol realized risk). By comparison, CRMD carries 56.3% implied volatility (25th %ile, Compressed (<25th %ile)), a 0.69x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.20β · 107% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
CRMD vs RTX · Reverse Pair
RTX vs LMT
· Sector Peer
RTX vs NOC
· Sector Peer
RTX vs GD
· Sector Peer
CRMD vs VTVT
· Sector Peer
CRMD vs CAPR
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem